The Royal Society of Medicine (RSM) recently hosted a conference that had everyone buzzing with excitement with the latest neurotechnology demonstrations!
Neurotechnology was the star of the show, with delegates from all sectors eager to get their hands on the latest advancements and learn about the potential of this rapidly-growing field. Not to mention, the event was packed with renowned speakers who shared their research and insights on the topic.
All in all, it was a great success!
MiNT’s mission is to bridge the gap between neurotechnology, industry and society. During their packed agenda they shared how neurotechnology has the ability to integrate into all these environments, including within the NHS and clinical practices.
Without a doubt, Graham Cooper, the Stroke patient who participated in the demonstration, gave a witty and exciting talk on how Stroke affected him and how intensive rehabilitation has changed his life.
On the day, representatives from each faction congregated to strategise ways to modify the present state of Rehab practitioners in the UK and beyond, unifying their voices to obtain sway. Countless people declared that this sentiment must be conveyed to the government and our National Health Service.
Jen Mellows, Operations Lead from Hobbs Rehabilitation, remarked that it is vital for those who are responsible for establishing guidelines for rehab and health tech to recognise and incorporate neurotechnology in order to ensure patients get the appropriate rehabilitation at the appropriate time.
To make this possible, conversations with the Department of Health, Health Education England, NICE, regulators, NHS commissioners, private rehab providers, and industry are essential. On the ground level, clinicians and developers are already implementing the technology, but at a strategic, nationwide, and international level, it has yet to be recognised.
As a result, MiNT is working to bring these parties together in an effort to amplify their collective mission and spark change. Moreover, discussions have been held with other countries to ensure these actions are taking place in their environments.
MiNT welcomes individuals and organisations alike who are invested in neurotechnology.
Their network of clinicians, academics, researchers, case managers, engineers, technology developers, patients, and companies are invited to visit their website or email them at [email protected] to learn how you can participate.
